234 (PB222): Rational combination of pan-TEAD inhibitor SW-682 and MEK inhibitor mirdametinib in head and neck squamous cell carcinomas leads to synergistic response

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2024-10, Vol.211, p.114752, Article 114752
Main Authors: Schirmer, A., Chen, L., Celentano, L., Chanelo, A., Jove, V., DuBose, R., Saha, S., Johnson, M., Lawhorn, B., Gwaltney, S., Lin, T.A., de Marval, P. Miliani
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114752